Stocktwits on MSN
Ventyx’s $1.2B buyout by Eli Lilly proves timing often beats conviction in biotech investing — a VC explains
Booth said timing drove sharply different investor outcomes in Ventyx. ・Clear Street said Lilly was a logical buyer and cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback